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Introduction 
In the modern era of science, it is possible to get caught up with the chemical rush. Remedies 
that might have once worked for our ancestors are now ignored for the flashy medicines 
available over the counter. Amidst the excitement created by these chemicals, emerges an 
alternative to old age and new age medicines in the form of probiotics.  Probiotics are bacteria 
which are non-pathogenic and have a positive effect on the physiology and overall health of the 
host they live in (Kleta et al.). Much research has been done and many experiments have been 
performed to find out exactly which bacteria are most beneficial, and in what ways.  The main 
bacteria that have been examined in this study are various strains of the Lactobacillus and 
Bifidobacterium genus.  It can be said that there is variation in effectiveness not only between 
genii, but also between species within the same genus (Nikoskelainen et al.).     
Probiotics are bacteria, and are thought to be part of the natural flora in most animals.  
However, variation does exist between how much bacteria is between animals, and through 
this, arise problems (Kleta et al.). Pathogens which attack primarily the gastrointestinal tract 
have been examined in this study and it has been shown that probiotics provide prevention and 
relief against said pathogenic bacteria and associated symptoms (Olivares et al.) Aside from 
being a preventative measure as well as a somewhat “medicine”, probiotics are also given to 
non-breastfed infants as a supplement (Olivares et al.).  
There are several mechanisms through which probiotics aid the body in fighting off pathogens.  
These range from fighting for adhesion on the tract itself, to displaying some sort of 
antibacterial properties (Bouzaine et al.) Methods have also been developed to trace the 
progress of the probiotics after they have been ingested, and also to verify the effects of the 
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probiotics as they travel through the host body (Schultz et al.). Some people assume that as 
with modern medicine, probiotics have negative effects on the body.  However, this has been 
disproven through laboratory tests, thereby proving several probiotic bacterial species 
completely nontoxic and usable for humans (Hong et al.).  
A. Probiotics: A Closer Look 
Probiotic bacteria have shown to positively affect the composition of and activity of the 
intestinal microbiota, and have demonstrated that they have a beneficial effect in the host. 
They do this by preventing or reducing effects of certain gastrointestinal infections (Bouzaine et 
al.).  Especially in the last few years, much interest has accumulated for probiotic bacteria due 
to their potential benefits in the fields of normal intestinal microflora, stimulation of immune 
systems, relief in diarrhea, and other gastrointestinal afflictions (Morelli et al.). There are two 
main genii of interest where probiotics are concerned: Lactobacillus and Bifidobacterium.  In 
one study, experiments were performed with four strains of Lactobacillus: L. salivarius 
CECT5713, L. gasseri CECT5714, L. gasseri CECT5715 and L. fermentum CECT5716. Researchers 
found that L. salivarius was the most beneficial to humans (Olivares et al.).  Agar diffusion tests, 
competitive adhesion assays, and mucin expression assays were carried out in order to evaluate 
the antibacterial properties against pathogenic bacteria.  They were able to determine that not 
only was L. salivarius the best in terms of in-vitro antibacterial activity, but also provided the 
highest protective effect against a Salmonella strain in a murine infection model (Olivares et al.) 
Research has also shown that probiotic bacteria occur naturally in the gut micro flora of 
animals. For example, another species of probiotics, Escherichia coli Nissle 1917, has been 
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proven to occur naturally in swine micro flora.  However, further results of this experiment 
indicated that the colonization of individual animals can vary.  A study was conducted on the 
intestinal microflora of pigs, and the E. coli Nissle 1917 strain was isolated and identified, from 
the given population.  A feeding experiment was also conducted with four piglets, and it was 
found that they all showed viable E. coli Nissle 1917 in their intestines. Thus, Kleta and his 
colleagues concluded that this particular strain is pre-established in swine herds.  They did see, 
however, that the colonization in individual animals can be variable. Colon and jejunum (area of 
the small intestine) sections from three piglets were examined and the number of E. coli Nissle 
1917 isolates differed in all three, but was present at some level.  (Kleta et al.) 
Studies have also shown that some infections are more prevalent in organisms and people 
without a certain baseline level of probiotic bacteria. In addition to this, research has 
demonstrated that having the probiotic bacteria in one’s system before being infected leads to 
better recovery. For example, Helicobacter pylori infections are seen more heavily in people 
that we know already have a lower baseline level of Lactobacillus johnsonii La1. The clinical 
studies that were conducted show that the Lactobacillus family of bacteria has positive effects 
on patients with Helicobacter pylori infections. Results show that when the mouse models that 
were being tested were fed L. salivarius prior to the challenge with H. pylori, no colonization 
was achieved. Furthermore, when the animals were already infected with H. pylori, and were 
then fed L. salivarius, the numbers of the pathogens were reduced to less than 1% of the 
control group. (Hamilton-Miller et al.) 
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In another study, the scientists involved studied in vivo the effects of probiotics in infants with 
atopic eczema dermatitis syndrome (AEDS) and those infants with cow’s milk allergy (CMA).  
They had a total of 230 in vivo subjects and found that in atopic children, there were more 
coliforms and clostridia and fewer bifidobacteria and lactobacillus bacteria than nonatopic 
children (Viljanen et al.). Studies were conducted on the specific effect of probiotic bacteria on 
the specific effect of probiotic bacteria on the post treatment inflammation marker, C-reactive 
protein (CRP). The data presented in this particular study shows that there is a significant 
increase in the CRP levels in the Lactobacillus-treated infants with AEDS, than those infants in 
the control group.  This is beneficial since the production of Human CRP leads to inhibition of 
production of different inflammatory cytokines and chemokines. Human CRP also enhances the 
production of IL-10, which displays potent abilities to suppress the antigen presentation 
capacity of antigen presenting cells. It is also stimulatory towards certain T cells, mast cells and 
B cells (Viljanen et al.).  
Of course, there are many factors that affect probiotics, since they are living organisms.  Many 
properties which could have an effect on the Lactobacillus strains or their mechanisms were 
examined in a study.  The characteristics studied were acid and bile tolerance, adhesion and cell 
surface hydrophobicity, antimicrobial effect on common pathogens and cholesterol reduction.  
In vivo, all seven strains tested could survive at a pH of 3, which is significant since ingestion 
with food or dairy products raises the pH of the stomach to 3 or higher.  It was also seen that 
the tolerance of the tested strains to acid was highly strain-specific, since only 3 out of the 
seven exhibited good tolerance to simulated bile (Mishra et al.) 
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C. Uses 
Probiotic bacteria have a variety of uses in the present society. Primarily, they are used as a 
preventative measure against a variety of infections. In the study performed by Frick et al, the 
scientists tested whether strains modulating inflammatory reponses in vivo could prevent DSS-
induced acute colitis.   Key results were that they found that the probiotic bacteria increased 
the resistance of mice to the infection.  They also saw that the probiotic bacteria inhibited 
inflammatory processes in vivo.  The mouse model of oral Yersiniosis showed that the 
administration of viable B. adolescentis (the probiotic bacteria in question) protected mice from 
the generalization of Y. enterocolitica infection. In fact, in mice models with the dextran sodium 
sulfate-induced- colitis, B. adolescentis attenuated the development of colitis, indicating anti-
inflammatory properties.  (Frick et al.)  
 
Studies also show that certain probiotic bacteria can protect against various fish pathogens, 
Vibrio anguillarum, Aeromonas salmonicida, and Flavobacterium psychrophilum. These are of 
special importance to humans because these are common pathogens that infect fish used for 
human consumption.  It has been deduced that L. rhamnosus ATCC 53103 and L. bulgaricus can 
be considered for safe treatment in aquaculture (Nikoskelainen et al.) Adhesion, as will be 
discussed later, is one of the mechanisms by which probiotics are thought to benefit the host 
organism.  In a particular study conducted by Nikoskelainen and his colleagues, it was deduced 
that L. rhamnosus and L. bulgaricus were the most adhesive to the gastrointestinal tract. This 
ability is thought to be the way by which probiotics suppress pathogen growth.   
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Other uses for probiotics involve the commensal bacteria to be used as a neonatal nutrition 
source.  For example, research has shown that probiotic bacteria are transferred through breast 
milk from mother to infant (Olivares et al.) As mentioned previously, having proper intestinal 
flora is very important to gastrointestinal health. Thus, for infants that are not breast-fed, 
proper supplements must be given with the bacteria added to it, to ensure gut health. 
D. Mechanisms 
Studies have been performed to evaluate the adherence and colonization properties of the 
Lactobacillus rhamnosus TB1 strain, which is important since they know that the probiotic 
bacteria can localize and adhere to the GI tract, and thus provide competition to the pathogenic 
bacteria. This is one of the mechanisms by which probiotic bacteria provide resistance to 
pathogens (Bouzaine et al.) 
 
Different strains of Lactobacillus have shown to have varying degrees of adherence.  
Researchers tested the adhesive capacity of selected enterococci to human, canine, and 
porcine intestinal music was investigated in order to select for potential probiotic strains with 
good adhesive properties for human or animal use.  The key results were that a strong 
correlation was observed for the adhesion to human and canine intestinal mucus and also 
between porcine and canine or human mucus.  Two surface proteins have been identified that 
are associated with association and may be involved in adhesion of enteroccoci: the 
aggregation substance and enterococcal surface proteins (Laukova et al.)  The method by which 
probiotic adhesion blocks other bacteria can be seen in Figure 1, panels A-E. 
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Figure 1.  
 
 
 
 
 
 
 
 
 
 
 
 
We can see in Panels A and C, cells that have been infected by Salmonella enteridis for 40 (A) 
and 120 (B) minutes.  The pictures in panels (C) and (D) depict cells that hhave been infected by 
Salmonella enteridis, but have been incubated with cultures of Lactobacillus kefir. Panel (E) 
depicts uninfected cells, for comparison.  It can be seen that with the presence of the 
Lactobacillus bacteria, the adherence of the Salmonella is greatly reduced, therefore leading to 
healthier patients (Golowczyc et al.)   
While it has been established that adherence is key to Lactobacillus resistance of various 
gastrointestinal pathogens, studies have been done to examine where exactly the lactobacillus 
adheres to, to provide said resistance. The key results were that there were four sites of 
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recovery for the probiotic bacteria: the cecum, the transverse, the descending colon, the 
sigmoid colon (Morelli et al.). 
While competition is a strong mechanism of resistance, it is not the only one used by probiotics. 
Evidence has been given to show that probiotic bacteria Lactobacilli exert bacteriostatic or 
bactericidal effects against bacterial pathogens, namely, Helicobacter pylori (Cruchet et al.) 
Further research with this pathogen/probiotic shows that Lactobacillus not only kills it, but also 
prevents IL-8 release (Hamilton-Miller et al.) The authors speculate that the mechanism by 
which Lactobacillus blocks Helicobacter pylori is combination of the following: competition for 
nutrients, competition for exclusion, production of inhibitory compounds, and 
immunomodulatory stimuli (Hamilton-Miller et al.).  
Another species of bacteria that is affected by probiotics is N. gonorrhoeae.  Studies show that 
when probiotics are given to individuals who are infected with N. gonorrhoeae, symptoms are 
alleviated.  The mechanism by which this is achieved, is again, when the Lactobacillus 
administered binds to the cells and therefore preventing the adhesion of the pathogenic 
bacteria.  The adhesion results from the studies of Spurbeck and his colleagues can be seen in 
the figure below. 
Figure 2.  
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Gonococcal adherence is reduced significantly when there is lactobacillus present due to the 
fact that the two bacterial strains fight for competition. (Spurbeck et al.) 
The direct effect of probiotics on infants’ intestinal systems by measuring changes in systemic 
levels of cytokines and inflammatory markers has also been evaluated.  The researchers found 
that there was a significant increase in the levels of CRP (C-reactive protein) in infants treated 
with LGG, who had AEDS.  CRP is an indication of inflammation.  IL-6 induces gene activation of 
CRP in hepatocytes and it stimulates CRP secretion (Viljanen et al.)  
Post inoculation with probiotic bacteria, the protein composition of the host organism also 
changes. A study was done to evaluate exactly what and how changes, and the result this 
causes on the organism.  studies were performed in-vivo by inoculation of Lactobacillus 
fermentum into the rabbit jejunum for 4 hours.  After inoculation, the bacteria were analyzed 
for proteome.  The scientists performing this study found changes in protein biomarkers that 
are beneficial for Lactobacillus and intestinal epithelial cells in response to interactions. The key 
results were that there were undetectable values for Lactate dehydrogenase when L. 
fermentum is incubated inside rabbit jejunum.  This indicates that lactate utilization is limited as 
a fuel in intestinal bacterium.  There is also a decrease in dihydrolipoamide dehydrogenase, 
which is a component of the pyruvate dehydrogenase complex.  This suggests that oxidation of 
pyruvate via the krebs cycle is low post incubation. And since substrate oxidation is associated 
with the production of oxygen free radicals, which are potentially toxic to bacteria, these 
changes in energy metabolism would favor the survival of L. fermentum  in the intestine.  Lastly, 
there is an increase in Glycoside hydrolase, which plays a role in mucin degradation on the 
surface of the intestine.  The release of glycoside hydrolase from the bacterium may participate 
11 
 
in the regulation of mucin turnover and thus integrity of the intestinal epithelium.  Another 
important finding from this study is that the levels of some regulatory proteins were elevated in 
response to incubation with the probiotic, and some of these proteins would help protect 
against the inflammatory injury that occurs in response to bacteria.  They summarized that 
proteins can serve as biomarkers for the metabolic changes that are beneficial for the 
lactobacillus and intestinal epithelial cells (Yang et al.) 
 
E. Proof  of Activity 
There is a lot that can be said about the mechanisms and methods by which probiotics aid the 
human body, but where is the proof that this is actually happening? Scientists have thus come 
up with techniques to follow and track the progress of the probiotic bacteria through the 
gastrointestinal tract.  In a study mentioned previously, a tests were performed  in vivo and the 
scientists stained the bacteria with cFDA-SE and under observation, realized that the bacteria 
was localized in the rectum and also in the jejunum and ileum.  This is important since they 
know that the probiotic bacteria can localize and adhere to the GI tract, and thus provide 
competition to the pathogenic bacteria (Bouzaine et al.) 
 
Another method of tracking the progress of the probiotic through the GI tract is through GFP 
staining.  Scientists realized that bacteria can be difficult to follow through the gastrointestinal 
tract, so they decided to label it with a plasmid containing GFP.  They used rats for the in-vivo 
models, and then took samples from the stomach, jejunum, ileum, caecum, colon and rectum 
to test for presence of EcN.  They found that the EcN-GFP was detectable in high numbers in 
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the stomach and in lower numbers in the caecum but not in the rectum at the beginning of the 
experiment.  They also found out that the organisms were localized close to the epithelial 
surface of the stomach,  cecum, and rectum and also in the lumen of the intestine.  The 
transformation of EcN to obtain EcN-GFP in this study had no detectable influence on the 
probiotic microorganism regarding adhesion on and induction of IL-8 secretion of HT-29 cells 
and allowed the detection in mixed microbial environments (Schultz et al.)  
Figure 3. 
 
 
 
 
 
Figure 3 on depicts images of fluorescence microscopy of histological sections of the caecum 
from untreated controls (A, autofluorescence of intestinal tissues) and from mice challenged 
with EcN-GFP (B). EcN-GFP appears as a bright band close to the epithelial surface, and the 
treated animals display greater amounts of GFP, meaning greater amounts of resistance 
(Schultz et al.). 
 
F. Safety 
Probiotics as treatment are still a novel concept in the medical world, and leads to questions 
and doubts in the minds of many.  However, one can rest assured that studies are heavily 
underway to test for the safety and reliability of probiotics.  Research has been done to 
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determine any toxicity present through the usage of probiotic bacteria, Bacillus (subtilis and 
indicus).  Researchers tested guinea pigs and rabbits since they are considered the most 
sensitive lab animals.  No noticeable differences could be seen in the animals tested, thus they 
can assume that the probiotic bacteria are harmless (Hong et al.).  
G. Conclusions and Implications for the Future 
Probiotics are a wave of the current era that are not only already useful, but also have great 
scope in the years to come. Already being used as supplements, probiotic bacteria are still 
under heavy research to be understood better and improved for further human use. Currently, 
we use largely the Lactobacillus and Bifidobacterium species, but we must keep in mind that 
more research should be performed on other commensal bacteria that could potentially 
improve human health. These bacteria, already naturally present in many organisms naturally, 
can be used as "medicine" to prevent infections such as those caused by pathogens, and other 
benefits such as stimulation of immune systems and relief in various gastrointestinal afflictions. 
As mentioned, Lactobacillus bacteria are particularly important for humans, in particular 
Lactobacillus salivarius (Nikoskelainen et al.).  In addition, another species of bacteria - 
Escherichia coli have been proven to occur naturally in swine micro flora and that they are 
particularly beneficial for intestinal health (Kleta et al.).   
Research suggets several mechanisms by which probiotics accomplish the beneficial results in 
their host organisms.  Largely, evidence shows that competitive adherence is the key to the 
probiotic success.  Four major sites of adherence have been established: the cecum, the 
transverse, the descending colon and the sigmoid colon (Morelli et al.). Another mechanism 
14 
 
suggested is the bactericidal affects of probiotics - and release of Interleukins (Hamilton-Miller 
et al.) 
Probiotic bacteria have also been tracked through the body to verify their adherence and 
effects, through cFDA-SE staining. It has been established that probiotic bacteria can localize 
and adhere to the GI tract, and thus compete with pathogenic bacteria (Bouzaine et al.). GFP 
staining has also been used to verify the presence and adherence of probiotic bacteria 
throughout organisms (Schultz et al.). 
Safety is an aspect of probiotic research that, though already tested and proven positive, needs 
to be further researched.  Positive results have been obtained in rabbit and guinea pig models 
(Hong et al.), but not enough studies have truly examined all the effects of bacterial 
supplements to humans. This is particularly important, since we must be sure of the effects 
before administering probiotic bacteria to certain members of the population- such as infants, 
elderly and other high-risk individuals. 
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